Hikmet Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hikmet Yilmaz has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ayşın Kısabay Ak
Department of Neurology, Celal Bayar University, Manisa, Turkey
5 shared publications - Melike Batum
Department of Neurology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Türkiye
5 shared publications - Deniz Selçuki
Department of Neurology, Celal Bayar University Medical School Hafsa Sultan Hospital, Manisa, Turkey
4 shared publications Bilge Oktan
2 shared publications- Emin Kurt
Department of Ophthalmology, Celal Bayar University
2 shared publications - Hüseyin Mayalı
Manisa Celal Bayar Univ, Fac Med, Dept Ophthalmol, Manisa, Turkiye
2 shared publications
Latest Publications
- 5 August 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109092
Comparison of the effects of greater occipital nerve blockage versus combined greater occipital nerve and supraorbital nerve blockage therapy on sleep, pain, anxiety, depression, and quality of life in chronic migraine
- 5 August 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109092
Comparison of the effects of greater occipital nerve blockage versus combined greater occipital nerve and supraorbital nerve blockage therapy on sleep, pain, anxiety, depression, and quality of life in chronic migraine
- 6 June 2020
- Published by Springer Nature in International Ophthalmology
- Vol. 40 (10) , 2475-2485
Evaluation of effects of positive airway pressure treatment on retinal fiber thickness and visual pathways using optic coherence tomography and visual evoked potentials in the patients with severe obstructive sleep apnea syndrome
Introduction Hypoxia during sleep in obstructive sleep apnea syndrome (OSAS) increases intracranial pressure, decreases cerebral perfusion pressure, and alters vascular supply to the optic nerve. Pattern visual evoked potential (pVEP) has revealed that it causes alterations in the optic nerve, and optic coherence tomography has shown that it causes alterations in the retinal and macular layers. Objectives To detect and compare possible alterations in macula and peripapillary retinal nerve fiber thickness (pRNFL) using OCT and in the optic nerve pathways using pVEP before and after positive airway pressure (PAP) in the patients with severe OSAS. Materials and methods Thirty patients who were diagnosed as having severe OSAS in the neurology-sleep outpatient clinic and 30 healthy control subjects were included in the study. Ophthalmic examinations were performed prior to (month 0) and after (month 6) PAP treatment, and pVEP (peak time [PT] and amplitude) and OCT parameters (peripapillary retinal-macular layers) were compared. Results In the comparison between the severe OSAS (before treatment) and control groups, thinning was found in pRNFL (average, nasal, inferior) and in the macular layers (external and internal superior quadrants) (p < 0.05). pVEP investigation revealed increased PT in P100 and N145 waves and decreased amplitude of N75–P100 waves. In the comparisons before and after PAP treatment, a decrease in PT of N75 and P100 waves and increase in N75–P100 amplitudes were found. In the pRNFL, significant thickening was found in the layers with thinning before treatment, whereas no significant thickening was found in macular layers, except for the fovea. Discussion It was shown that PAP treatment in patients with severe OSAS prevents hypoxia without causing alterations in intraocular pressure and thus reduces inflammation and causes thickening in the pRNFL and macular layers.
- 6 June 2020
- Published by Springer Nature in International Ophthalmology
- Vol. 40 (10) , 2475-2485
Evaluation of effects of positive airway pressure treatment on retinal fiber thickness and visual pathways using optic coherence tomography and visual evoked potentials in the patients with severe obstructive sleep apnea syndrome
Introduction Hypoxia during sleep in obstructive sleep apnea syndrome (OSAS) increases intracranial pressure, decreases cerebral perfusion pressure, and alters vascular supply to the optic nerve. Pattern visual evoked potential (pVEP) has revealed that it causes alterations in the optic nerve, and optic coherence tomography has shown that it causes alterations in the retinal and macular layers. Objectives To detect and compare possible alterations in macula and peripapillary retinal nerve fiber thickness (pRNFL) using OCT and in the optic nerve pathways using pVEP before and after positive airway pressure (PAP) in the patients with severe OSAS. Materials and methods Thirty patients who were diagnosed as having severe OSAS in the neurology-sleep outpatient clinic and 30 healthy control subjects were included in the study. Ophthalmic examinations were performed prior to (month 0) and after (month 6) PAP treatment, and pVEP (peak time [PT] and amplitude) and OCT parameters (peripapillary retinal-macular layers) were compared. Results In the comparison between the severe OSAS (before treatment) and control groups, thinning was found in pRNFL (average, nasal, inferior) and in the macular layers (external and internal superior quadrants) (p < 0.05). pVEP investigation revealed increased PT in P100 and N145 waves and decreased amplitude of N75–P100 waves. In the comparisons before and after PAP treatment, a decrease in PT of N75 and P100 waves and increase in N75–P100 amplitudes were found. In the pRNFL, significant thickening was found in the layers with thinning before treatment, whereas no significant thickening was found in macular layers, except for the fovea. Discussion It was shown that PAP treatment in patients with severe OSAS prevents hypoxia without causing alterations in intraocular pressure and thus reduces inflammation and causes thickening in the pRNFL and macular layers.
- 24 January 2020
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 141 (1) , 33-43
Evaluation of retinal fiber thickness and visual pathways with optic coherence tomography and pattern visual evoked potential in different clinical stages of obstructive sleep apnea syndrome
To investigate the possible changes in retinal nerve fiber layer (RNFL) by optic coherence tomography and in the amplitudes and peak times (PTs) in pattern visual evoked potential (pVEP) and to compare them in obstructive sleep apnea syndrome (OSAS).
- 24 January 2020
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 141 (1) , 33-43
Evaluation of retinal fiber thickness and visual pathways with optic coherence tomography and pattern visual evoked potential in different clinical stages of obstructive sleep apnea syndrome
To investigate the possible changes in retinal nerve fiber layer (RNFL) by optic coherence tomography and in the amplitudes and peak times (PTs) in pattern visual evoked potential (pVEP) and to compare them in obstructive sleep apnea syndrome (OSAS).
- 1 July 2016
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 50 (4) , 284-287
Association of myasthenia gravis and Behçet's disease: A case report
Myasthenia gravis is a disease of neuromuscular junction due to auto-immune destruction of the acetylcholine receptors. Behçet's disease, on the other hand, is a multisystemic vascular-inflammatory disease. Both conditions are not common in the general population although their association has not been reported in the literature. We wanted to present our patient who developed clinical course of myasthenia gravis following discontinuation of medications due to complications of corticosteroid for Behçet's disease. It was observed that clinical findings of myasthenia gravis recovered following restarting steroid treatment and he did not experience attacks of both conditions. Although Myasthenia gravis and Behçet's disease are distinct entities clinically as well as in terms of pathogenesis, they share common physiopathological features and their treatment is based on their common features.
- 1 July 2016
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 50 (4) , 284-287
Association of myasthenia gravis and Behçet's disease: A case report
Myasthenia gravis is a disease of neuromuscular junction due to auto-immune destruction of the acetylcholine receptors. Behçet's disease, on the other hand, is a multisystemic vascular-inflammatory disease. Both conditions are not common in the general population although their association has not been reported in the literature. We wanted to present our patient who developed clinical course of myasthenia gravis following discontinuation of medications due to complications of corticosteroid for Behçet's disease. It was observed that clinical findings of myasthenia gravis recovered following restarting steroid treatment and he did not experience attacks of both conditions. Although Myasthenia gravis and Behçet's disease are distinct entities clinically as well as in terms of pathogenesis, they share common physiopathological features and their treatment is based on their common features.
- 6 April 2016
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 116 (4) , 605-613
Evaluation of neurodegeneration through visual evoked potentials in restless legs syndrome
- 6 April 2016
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 116 (4) , 605-613
Evaluation of neurodegeneration through visual evoked potentials in restless legs syndrome
- Open Access
- 18 January 2016
- Published by Journal Of Medical And Surgical Intensive Care Medicine in Journal of Critical and Intensive Care
- Vol. 6 (3) , 104-110
Intravenous Amantadine in Percheron Artery Syndrome: Three Cases
- 18 January 2016
- Published by Journal Of Medical And Surgical Intensive Care Medicine in Journal of Critical and Intensive Care
- Vol. 6 (3) , 104-110
Open AccessIntravenous Amantadine in Percheron Artery Syndrome: Three Cases
- 1 January 2016
- Published by LookUs Bilisim A.S. in Respiratory Case Reports
- Vol. 5 (1) , 71-74
Sleep Respiratuar Disorder in A Child with Congenital Bone Dysplasias: A Case of Report
- 1 January 2016
- Published by LookUs Bilisim A.S. in Respiratory Case Reports
- Vol. 5 (1) , 71-74
Sleep Respiratuar Disorder in A Child with Congenital Bone Dysplasias: A Case of Report
- 1 February 2007
- Published by IMR Press in The Heart Surgery Forum
- Vol. 10 (1) , E16-E20
Objective and Subjective Characteristics of Sleep after Coronary Artery Bypass Graft Surgery in the Early Period: A Prospective Study with Healthy Subjects
The purpose of this study was to investigate changes in sleep characteristics by examining both subjective tests and objective parameters such as actigraphic sleep analysis in patients who underwent coronary artery bypass graft surgery (CABG). Forty-five patients who underwent CABG operations and did not have any sleep disturbance were examined. They were evaluated by subjective and objective sleep parameters at the beginning of the examination and on the fifth postoperative day. Forty healthy subjects who did not undergo the operation were also evaluated. The Pittsburgh Index and Epworth values in the postoperative group were significantly higher, but Maintenance of Wakefulness Test lengths were significantly shorter than in the preoperative and control groups. Sleep latency, napping episodes, total napping periods, and fragmentation index values of the postoperative group were significantly higher, but sleep efficiency values were significantly lower than in the preoperative and control groups. The cause of sleeplessness after CABG surgery may be the temporary deterioration of circulation in the centers of the brain stem and hypothalamus, which control sleep and awakening. It can be proposed that the improvement of the circulation in these centers a couple of months after the operation help to regain sleep control, and thus sleep disturbances disappear.
- 1 February 2007
- Published by IMR Press in The Heart Surgery Forum
- Vol. 10 (1) , E16-E20
Objective and Subjective Characteristics of Sleep after Coronary Artery Bypass Graft Surgery in the Early Period: A Prospective Study with Healthy Subjects
The purpose of this study was to investigate changes in sleep characteristics by examining both subjective tests and objective parameters such as actigraphic sleep analysis in patients who underwent coronary artery bypass graft surgery (CABG). Forty-five patients who underwent CABG operations and did not have any sleep disturbance were examined. They were evaluated by subjective and objective sleep parameters at the beginning of the examination and on the fifth postoperative day. Forty healthy subjects who did not undergo the operation were also evaluated. The Pittsburgh Index and Epworth values in the postoperative group were significantly higher, but Maintenance of Wakefulness Test lengths were significantly shorter than in the preoperative and control groups. Sleep latency, napping episodes, total napping periods, and fragmentation index values of the postoperative group were significantly higher, but sleep efficiency values were significantly lower than in the preoperative and control groups. The cause of sleeplessness after CABG surgery may be the temporary deterioration of circulation in the centers of the brain stem and hypothalamus, which control sleep and awakening. It can be proposed that the improvement of the circulation in these centers a couple of months after the operation help to regain sleep control, and thus sleep disturbances disappear.
- 1 January 2007
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 12 (4) , 348-350
Late daytime naps may cause drowsiness after coronary bypass graft operation in the first postoperative week
- 1 January 2007
- Published by Armed Forces Medical Services in Neurosciences
- Vol. 12 (4) , 348-350
Late daytime naps may cause drowsiness after coronary bypass graft operation in the first postoperative week
- Open Access
- 1 January 2007
- Published by Wiley in Behavioural Neurology
- Vol. 18 (3) , 165-170
Comparison of Motor Activity and Sleep in Patients with Complex Partial Seizures on Levetiracetam Treatment and a Group of Healthy Subjects
Purpose: Levetiracetam‐treated patients commonly report daytime drowsiness, fatique, asthenia and decreasing of motor activity. However the origin of these reported side effects are still debated, we aimed to clarify effect of levetiracetam on sleep. Therefore this prospective study was conducted to evaluate the effects of levetiracetam on motor activity, amount and continuity of sleep and napping.Methods: Various tests were performed on twenty two patients treated with levetiracetam (10 monotherapy, 12 add‐on therapy) at least three days before the initiation of treatment, and consecutively for five to eight days at the third week of treatment. These tests included sleep logs, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, Modified Maintenance of Wakefulness Test and actimetric measurements. In order to evaluate the sleep behavior of these patients the following sleep parameters were estimated: bedtime, wake‐up time, sleep‐onset time, sleep‐offset time, sleep latency, total sleep time, wake time after sleep onset, fragmentation index, total activity score, nap episodes, total nap duration and sleep efficiency. Twenty members of staff from our hospital (Doctor, nurse, secretary, civil servant etc.) were evaluated as control subjects in the study.Results: After three‐week treatment with levetiracetam (in particular with add‐on therapy), Epworth Sleepiness Scale scores, napping episodes and total nap durations increased and sleep latencies decreased. While durations of Modified Maintenance of Wakefulness Test and total activity scores decreased. However the total sleep time and the sleep efficiency did not show any difference from the pre‐treatment values.Conclusions: Our results suggest that levetiracetam leads to drowsiness by decreasing the daily motor activity and increasing the naps; however this agent does not have any major effects on total sleep time and sleep efficiency during night. Actimetric analyses give information about continuity of sleep and sleep/wake states however does not give satisfactory information about architecture of sleep. In order to determine the effects of levetiracetam on the sleep architecture we need similiar protocol studies by full night polysomnography.
- 1 January 2007
- Published by Wiley in Behavioural Neurology
- Vol. 18 (3) , 165-170
Open AccessComparison of Motor Activity and Sleep in Patients with Complex Partial Seizures on Levetiracetam Treatment and a Group of Healthy Subjects
Purpose: Levetiracetam‐treated patients commonly report daytime drowsiness, fatique, asthenia and decreasing of motor activity. However the origin of these reported side effects are still debated, we aimed to clarify effect of levetiracetam on sleep. Therefore this prospective study was conducted to evaluate the effects of levetiracetam on motor activity, amount and continuity of sleep and napping.Methods: Various tests were performed on twenty two patients treated with levetiracetam (10 monotherapy, 12 add‐on therapy) at least three days before the initiation of treatment, and consecutively for five to eight days at the third week of treatment. These tests included sleep logs, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, Modified Maintenance of Wakefulness Test and actimetric measurements. In order to evaluate the sleep behavior of these patients the following sleep parameters were estimated: bedtime, wake‐up time, sleep‐onset time, sleep‐offset time, sleep latency, total sleep time, wake time after sleep onset, fragmentation index, total activity score, nap episodes, total nap duration and sleep efficiency. Twenty members of staff from our hospital (Doctor, nurse, secretary, civil servant etc.) were evaluated as control subjects in the study.Results: After three‐week treatment with levetiracetam (in particular with add‐on therapy), Epworth Sleepiness Scale scores, napping episodes and total nap durations increased and sleep latencies decreased. While durations of Modified Maintenance of Wakefulness Test and total activity scores decreased. However the total sleep time and the sleep efficiency did not show any difference from the pre‐treatment values.Conclusions: Our results suggest that levetiracetam leads to drowsiness by decreasing the daily motor activity and increasing the naps; however this agent does not have any major effects on total sleep time and sleep efficiency during night. Actimetric analyses give information about continuity of sleep and sleep/wake states however does not give satisfactory information about architecture of sleep. In order to determine the effects of levetiracetam on the sleep architecture we need similiar protocol studies by full night polysomnography.